Stem cells and cell-based therapies for cerebral palsy: a call for rigor-Reference-Cited by-同舟云学术

Stem cells and cell-based therapies for cerebral palsy: a call for rigor

Published:2017-11-01 Issue:1-2 Volume:83 Page:345-355
ISSN:0031-3998
Container-title:Pediatric Research
language:en
Short-container-title:Pediatr Res

Author:

Jantzie Lauren L,Scafidi Joseph,Robinson Shenandoah

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://www.nature.com/articles/pr2017233.pdf

Reference118 articles.

1. Rosenbaum P, Paneth N, Leviton A et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007;109:8–14.

2. Toyokawa S, Maeda E, Kobayashi Y . Estimation of the number of children with cerebral palsy using nationwide health insurance claims data in Japan. Dev Med Child Neurol 2017;59:317–321.

3. Durkin MS, Benedict RE, Christensen D et al. Prevalence of cerebral palsy among 8-year-old children in 2010 and preliminary evidence of trends in its relationship to low birthweight. Paediatr Perinat Epidemiol 2016;30:496–510.

4. Hollung SJ, Vik T, Wiik R et al. Completeness and correctness of cerebral palsy diagnoses in two health registers: implications for estimating prevalence. Dev Med Child Neurol 2017;59:402–406.

5. Alriksson-Schmidt A, Nordmark E, Czuba T et al. Stability of the Gross Motor Function Classification System in children and adolescents with cerebral palsy: a retrospective cohort registry study. Dev Med Child Neurol 2017;59:641–646.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy;World Journal of Clinical Cases;2024-03-26

2. Progress in the treatment of neonatal hypoxic-ischemic encephalopathy with umbilical cord blood mononuclear cells;Brain and Development;2023-11

3. Assessment Scales in Cerebral Palsy: A Comprehensive Review of Tools and Applications;Cureus;2023-10-30

4. Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight;Scientific Reports;2023-03-07

5. The Impact of an Adverse Intrauterine Environment on Neurodevelopment;Neurodevelopmental Pediatrics;2023